Take part in the international conference and exhibition "Ingredients and Additives".In 2022, the event will take place on the territory of Technopark Skolkovo innovation...
RDIF, AstraZeneca and Unicorn Capital Partners invest in Target Medicals, developing aldosterone synthase inhibitor for the treatment of resistant arterial hypertension.
The Russian Direct Investment...